The documents in this section will assist in the implementation of new advanced therapy services in a clinical setting, supporting the transition of guidance into practice. Documents include process and patient flow charts to map the treatment pathway and information on the in-hospital logistics requirements.
PDF
01.06.2020
A document summarising the challenges and solutions the the collection of starting materials for ATMP manufacture though apheresis
PDF
27.02.2023
Training package to prove nurses with knowledge, skills and expertise to perform specific apheresis procedures for cellular therapy in a safe and professional manner.
XLSX
27.02.2023
A template produced by The Christie NHS Trust to hold and update frequently asked questions and responses to cell therapy trial feasibility questionnaires.
PDF
16.11.2020
This document sets out an example generic checklist for allogeneic, cryopreserved, cellular Advanced Therapy Medicinal Products (ATMPs).
PDF
18.11.2020
This document sets out an example generic checklist for autologous, cryopreserved, cellular Advanced Therapy Medicinal Products (ATMPs)
PDF
18.11.2020
This document sets out an example generic checklist for receipt and storage of fresh, allogeneic, cellular Advanced Therapy Medicinal Products
PDF
11.06.2021
Form to complete when receiving, processing and releasing fresh cells for manufacturing
PDF
15.09.2021
A checklist to confirm ATMP is received appropriately from the manufacturer prior to administration to a patient
PDF
Job Description detailing the key responsibilities, skills and behaviours applicable for an Aseptics and Cellular Therapies Pharmacist
PDF
02.03.2020
A summary of activities across NA-ATTC hospitals geared towards patient centred, safe and efficient trial set-up, delivery and completion
PDF
31.05.2022
An overview of points to consider and SOPs required when establishing a new pathway for the collection of tissues to isolate tumour infiltrating lymphocytes (TIL). Relevant for both research and clinical tissue collection.
PDF
31.05.2022
SOP re: consenting Hepato-Pancreatico-Biliary (HBP) patients for biobank